A case report on the effective and safe use of ravulizumab in atypical hemolytic uremic syndrome during pregnancy
Abstract Background Atypical hemolytic uremic Syndrome (aHUS), a form of thrombotic microangiopathy (TMA), had a poor prognosis until the development of complement C5-inhibiting monoclonal antibodies, eculizumab and ravulizumab. While ravulizumab has shown effectiveness in treating postpartum TMA, d...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2026-04-01
|
| Seria: | BMC Nephrology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s12882-026-04950-w |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|